Component
Major coronary events in the Xuezhikang secondary-prevention trial
Context-specific entity; species, compartment and exposure are stated on each claim.
1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What acts on it
Over an average 4.5 years, major coronary events occurred in 5.7% of the Xuezhikang group versus 10.4% of placebo in nearly 5,000 Chinese patients with prior myocardial infarction.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Randomized secondary-prevention trial; partially purified Xuezhikang preparation.
- limitations
- Not proof for arbitrary supplements, primary prevention or isolated pigment effects; event reduction is not itself a molecular mechanism.
- nutrient_topic
- Red yeast rice collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Red yeast rice
- plain_language
- A specific extract had cardiovascular-outcome evidence in a defined population.
- primary_references
- [18549841] Effect of Xuezhikang, an extract from red yeast Chinese rice, on coronary events in a Chinese population with previous myocardial infarction. · 2008 · https://pubmed.ncbi.nlm.nih.gov/18549841/ · DOI 10.1016/j.amjcard.2008.02.056
Red yeast rice: constituents, mevalonate, CoQ and product-specific interactions (2026-09-20) · lines 364–370
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Randomized secondary-prevention trial; partially purified Xuezhikang preparation. · source_derived_draft · unverified_draft
## red-yeast-rice-xuezhikang-events A specific extract had cardiovascular-outcome evidence in a defined population. Over an average 4.5 years, major coronary events occurred in 5.7% of the Xuezhikang group versus 10.4% of placebo in nearly 5,000 Chinese patients with prior myocardial infarction. Model: Randomized secondary-prevention trial; partially purified Xuezhikang preparation. Limitations: Not proof for arbitrary supplements, primary prevention or isolated pigment effects; event reduction is not itself a molecular mechanism. Evidence access: Primary abstract [18549841] Effect of Xuezhikang, an extract from red yeast Chinese rice, on coronary events in a Chinese population with previous myocardial infarction. · 2008 · https://pubmed.ncbi.nlm.nih.gov/18549841/ · DOI 10.1016/j.amjcard.2008.02.056
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.